| 刊名 | Medicinal Plant |
| 作者 | Sun SUN, Jiangcun WEI, Hao HUANG |
| 作者单位 | Guangxi International Zhuang Medicine Hospital, Nanning 530201, China |
| DOI | DOI:10.19600/j.cnki.issn2152-3924.2026.02.012 |
| 年份 | 2026 |
| 刊期 | 2 |
| 页码 | 49-51，65 |
| 关键词 | Internet +, Pharmaceutical care model, Hypertension, Blood level, Medication safety |
| 摘要 | [Objectives] To investigate the impact of the "Internet+" pharmaceutical care model on blood pressure control and medication safety in patients with hypertension. [Methods] This randomized controlled study enrolled 86 hypertensive patients treated at Guangxi International Zhuang Medicine Hospital from January 2023 to December 2024. Of these, 43 patients receiving standard medication guidance were assigned to the control group, while the other 43, who received the "Internet+" pharmaceutical care model, comprised the study group. Patient outcomes were assessed using the Morisky Medication Adherence Scale and the Self-Management Scale for Patients with Hypertension (SMSPH) on the day after admission (pre-intervention) and one month post-discharge (post-intervention). The analysis compared blood pressure levels between the two groups both before and after the intervention, and documented any adverse drug reactions occurring during the study period. [Results] Before the intervention, there were no significant differences between the two groups in Morisky scale scores, SMSPH scale scores, or blood pressure levels (systolic and diastolic) (P > 0.05). After the intervention, the scores on the Morisky scale and SMSPH scale in the study group were significantly higher than those in the control group (P < 0.05). In addition, the systolic and diastolic blood pressure levels in the study group were significantly lower than those in the control group and closer to the normal range (P < 0.05). The incidence of adverse drug reactions in the study group was significantly lower than that in the control group (P < 0.05). [Conclusions] The "Internet+" pharmaceutical care model is conducive to improving the rate of blood pressure control, medication safety, and adherence in patients with hypertension. It also helps patients acquire disease-related knowledge and correct unhealthy behaviors, which supports their long-term maintenance of both the behavior and cognition required for pharmacological treatment. |
